Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

RIGL Price Correlated With Financials For Rigel Pharmaceuticals

Free historical financial statements for Rigel Pharmaceuticals Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 41 quarters since 2012. Compare with RIGL stock chart to see long term trends.

RIGL Stock Compared to Quarterly

RIGL Income Statement

Revenue, Net:16735000
Revenue Per Share:0.0973
Cost of Goods & Services Sold:121000
Selling, General & Admin Expense:27401000
Research & Development Expense:15474000
Total Operating Expenses:42996000
Operating Income:-27445000
Income Taxes:0
Net Income:-27445000
Earnings Per Share, Basic:-0.16
Shares Outstanding, Basic Avg:172052224

RIGL Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:237000
Change in Accounts Receiveable:-232000
Net Cash from Operations:-25637000
Net Cash from Operations Per Share:-0.149
Net Cash from Financing Activities:8797000
Property, Plant & Equipment Purchases:224000
Net Cash from Investing Activities:22629000
Net Change in Cash & Equivalents:5789000

RIGL Balance Sheet

Cash and Cash Equivalents:107500000
Short-Term Investments:82840000
Accounts Receivable, Net:15240000
Inventories:6764000
Total Current Assets:138938000
Property, Plant & Equipment, Net:2140000
Total Assets:149074000
Accounts Payable:4614000
Total Short-Term Liabilities:59225000

Insider Trading

 
Change
Value
Transaction
SEC Form 4
RODRIGUEZ RAUL R   CEO, President
1,000,000 sh at $1
$688,400
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
FMR LLC
24,181,804 sh
-389,789 sh
-2%
$72,303
$7,189
Blackrock Inc.
16,573,646 sh
21,662 sh
0%
$49,555
$5,691
Vanguard Group Inc
9,132,210 sh
104,096 sh
1%
$27,305
$3,380
Invesco Ltd.
5,161,717 sh
-482 sh
0%
$15,435
$1,755
Lord, Abbett & Co. LLC
4,409,833 sh
77,225 sh
2%
$13,185
$1,704
Great Point Partners LLC
4,000,000 sh
-1,000,000 sh
-20%
$11,960
-$1,290
Tamarack Advisers, Lp
3,250,000 sh
3,245,000 sh
64900%
$9,718
$9,618
Geode Capital Management, LLC
3,059,728 sh
-52,932 sh
-2%
$9,148
$900
Ikarian Capital, LLC
2,137,128 sh
1,697,772 sh
386%
$6,390
$5,226
Northern Trust Corp
1,700,225 sh
-79,230 sh
-4%
$5,084
$368
Dimensional Fund Advisors LP
1,475,083 sh
-258,276 sh
-15%
$4,411
-$182
Sector Gamma As
1,466,678 sh
-2,926 sh
0%
$4,385
$491
Candriam Luxembourg S.C.A.
1,429,630 sh
-792,066 sh
-36%
$4,274
-$1,613
Rhenman & Partners Asset Management Ab
1,277,770 sh
-242,230 sh
-16%
$3,821
-$253
Morgan Stanley
1,136,500 sh
268,591 sh
31%
$3,399
$1,098
Charles Schwab Investment Management Inc
870,693 sh
27,762 sh
3%
$2,604
$370
Acadian Asset Management LLC
812,793 sh
227,423 sh
39%
$2,429
$880
CM Management, LLC
775,000 sh
 
$2,317
Assenagon Asset Management S.A.
753,110 sh
753,110 sh
NEW
$2,252
$2,252
Bank Of New York Mellon Corp
553,621 sh
1,447 sh
0%
$1,656
$193

Data imported from Rigel Pharmaceuticals Inc SEC filings. Check original filings before making any investment decision.